secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nemaura Medical Inc. (—)
CIK:        0001602078
Form:       8-K
Filed at:   2024-01-03T23:59:59+00:00
Accession:  0001079973-24-000008
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nemaura Medical accepts Nasdaq delisting, moves to OTC Markets; suspension Jan 5, 2024
--------------------------------------------------------------------------------

- Board and management strategically decided to accept Nasdaq's determination to delist the company.
- Received written notice from Nasdaq Hearings Panel on January 3, 2024, confirming delisting.
- Trading on Nasdaq suspended effective January 5, 2024; company will not request review.
- Shares expected to trade on OTC Markets following suspension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1602078/000107997324000008/0001079973-24-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1602078/000107997324000008/nmra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-24-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer